Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells
- 7 October 2008
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 273 (2) , 257-265
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Twist Transcriptionally Up-regulates AKT2 in Breast Cancer Cells Leading to Increased Migration, Invasion, and Resistance to PaclitaxelCancer Research, 2007
- AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1Journal of Biological Chemistry, 2003
- PKB Binding ProteinsCell, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- PKB/AKT: functional insights from genetic modelsNature Reviews Molecular Cell Biology, 2001
- DIFFERENTIATION AND GROWTH POTENTIAL OF HUMAN OVARIAN SURFACE EPITHELIAL CELLS EXPRESSING TEMPERATURE-SENSITIVE SV40 T ANTIGENIn Vitro Cellular & Developmental Biology - Animal, 2001
- Cellular survival: a play in three AktsGenes & Development, 1999
- Mechanisms and consequences of activation of protein kinase B/AktCurrent Opinion in Cell Biology, 1998
- PI3K: Downstream AKTion Blocks ApoptosisCell, 1997
- THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTSAnnual Review of Medicine, 1997